Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 95%
filed 2026-06-02
The filing discloses an unregistered private placement of 28,949 shares of common stock to the CEO/President/Director at $1.7272 per share for $50,000 in gross proceeds, completed May 29, 2026. The transaction is explicitly disclosed under Item 1.01 (Material Definitive Agreement) and Item 3.02 (Unregistered Sale of Equity Securities), relying on Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive equity issuance to an insider that increases the CEO's ownership from approximately 10.38% to 11.3% (including spouse holdings), materially affecting shareholder ownership structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-02
The filing discloses regulatory approval on May 28, 2026 of a material asset sale by Onity to Finance of America Reverse LLC involving a reverse mortgage servicing portfolio of approximately 20,000 loans with $5.1 billion unpaid principal balance, plus a three-year subservicing arrangement. This constitutes a material disposition of assets that would significantly affect investor assessment of the company's business and financial position, though the transaction remains subject to closing conditions.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-02
The filing discloses a trade libel lawsuit filed by Dragonfly Energy Holdings Corp. against William Errol Prowse IV and Prowse Publications LLC on June 1, 2026, alleging a sustained campaign of false and misleading statements that caused financial and reputational harm to the company's Battle Born Batteries brand. The complaint seeks damages and injunctive relief, making this a material litigation event that would affect a reasonable investor's assessment of the company's reputation, brand value, and potential financial exposure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-02
Cingulate Inc. disclosed that the FDA issued a Complete Response Letter (CRL) for its New Drug Application for CTx-1301, a dexmethylphenidate HCl treatment for ADHD. While the FDA did not raise safety or efficacy concerns and the company expects to resubmit, a CRL represents a material regulatory setback that delays commercialization of a key pipeline asset. This does not fit neatly into the predefined taxonomy (not a restatement, impairment, litigation, or going-concern disclosure), making "other_material" the most appropriate classification for this significant regulatory development.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-02
Celcuity disclosed detailed Phase 3 clinical trial results for gedatolisib (VIKTORIA-1) showing statistically significant efficacy improvements over a comparator drug, with the company anticipating FDA approval in Q3 2026 and commercial launch. While this is a material clinical milestone for a biotech company with an NDA under Priority Review, it does not fit neatly into the standard 8-K event taxonomy—it is neither an earnings release (no financial results), nor a regulatory approval (approval is anticipated, not granted), nor a material impairment or litigation. The disclosure is clearly material to investors assessing the company's pipeline and regulatory prospects, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-02
The 8-K discloses financial results for the three months ended March 31, 2026 via a press release issued on June 2, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release disclosure, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-02
Item 2.02 discloses that on June 2, 2026, Boost Run Inc. released an investor presentation containing "financial and operating information regarding the Company's performance, including annual recurring revenue, contracted revenue backlog, and other key metrics." This constitutes a disclosure of financial and operating results, which is the hallmark of an earnings_release event. The presentation is furnished as Exhibit 99.1 and covers key performance metrics as of June 1, 2026.
View raw filing on EDGAR →
8-K
Restatement
confidence 95%
filed 2026-06-02
Item 4.02 discloses that INVO Fertility's previously issued unaudited consolidated financial statements for Q1, Q2, and Q3 2025 are being restated due to multiple accounting errors identified in an internal review. The errors involve derivative and debt extinguishment accounting, preferred stock classification, convertible debentures, warrant classification, and debt amendment treatment. The audit committee concluded on June 1, 2026 that the three quarterly reports (10-Qs filed May 20, August 14, and November 17, 2025) should no longer be relied upon, with restatement to be presented in the 2025 Form 10-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-02
Item 2.02 discloses that INVO Fertility issued a press release on June 2, 2026 announcing financial results for the year ended December 31, 2025, with the press release furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 of Form 8-K.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-02
The filing discloses a U.S. Army order with a total purchase price of approximately $743,000, announced via press release on June 2, 2026. While this represents a material contract award for a small-cap company (SPAI), it does not fit cleanly into the standard 8-K event taxonomy—it is neither an earnings release, M&A activity, nor a financial restatement. The disclosure is material to investors as a significant customer order, but the specific event type is best classified as "other_material" given the absence of a dedicated category for material contract awards or customer orders.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-02
The filing discloses initiation of a multi-site Method Comparison Study to support FDA 510(k) submission for market clearance of the company's Intelligent Fingerprinting Drug Screening System for opiate codeine. This represents a material regulatory milestone in the product development pathway that would affect investor assessment of the company's commercialization prospects, but does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, executive change, or other specifically defined event types).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-02
The filing discloses an unregistered sale of securities under Item 3.02, specifically a convertible promissory note ($385,000 principal with $35,000 original discount) and a warrant to purchase 48,125 shares, both issued to an accredited investor on May 19, 2026. The securities were offered in reliance on Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive issuance involving convertible debt and equity warrants that will result in significant shareholder dilution upon conversion and exercise.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-02
Item 3.02 discloses an unregistered sale of equity securities completed on May 18, 2026, in which Leef Brands issued 33,146,842 Common Share Units at CN$0.25 per unit (raising approximately US$9.3 million), plus 11,084,132 Preferred Shares with 15% annual dividends and conversion rights. The securities are being offered pursuant to Section 4(a)(2) exemption and include warrants and convertible preferred shares, all of which are dilutive to existing shareholders. This is a material financing event typical of small-cap issuers raising capital through private placement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-02
The filing discloses unregistered sales of equity securities under Item 3.02: a private placement of 4,750 Units to the Sponsor (JKapital Ltd.) at $10.00 per Unit, generating $47,500 in gross proceeds, issued pursuant to Section 4(a)(2) of the Securities Act. This follows the Company's May 11, 2026 IPO and the May 20, 2026 partial exercise of the underwriters' over-allotment option. The private placement of Units—each consisting of one ordinary share and one right—represents a dilutive issuance of unregistered equity securities to an insider (the Sponsor).
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-02
Peace Acquisition Corp announced the separation and independent trading of its unit components (ordinary shares, rights, and warrants) effective June 4, 2026, with new Nasdaq ticker symbols for each component. While this is a structural capital markets event affecting how the company's securities trade, it does not fit cleanly into the standard 8-K taxonomy (not M&A, not an executive change, not a restatement, etc.). This is material to investors as it affects the liquidity and trading mechanics of their holdings, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-02
The filing discloses a 1-for-10 reverse stock split effective June 5, 2026, approved by the Board and previously authorized by stockholders. While reverse splits are structural corporate actions, this one is material because it directly addresses Nasdaq delisting risk—the Company states it is "effecting the Reverse Split in order to maintain compliance with the continued listing requirements" and to regain compliance with the $1 minimum bid price rule. The filing also notes that Adjustable Warrants will have significantly increased share counts and reduced exercise prices post-split, creating dilution. This is a material corporate restructuring driven by regulatory compliance concerns, but does not fit neatly into the delisting_risk category (which typically signals imminent delisting notice) nor the dilutive_issuance category (which covers new equity issuances). The reverse split itself is the primary disclosed event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-02
The filing discloses results of the 2026 Annual Meeting of Stockholders held on June 2, 2026, with certified voting results for three proposals: re-election of two directors (Jack K Heilbron and James R Durfey), ratification of Baker Tilly US, LLP as independent auditor, and approval of an amendment to the 2017 Incentive Award Plan increasing available shares to 550,000 and revising the evergreen provision. This is a classic Item 5.07 shareholder vote results disclosure with final certified tallies.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-02
The filing discloses entry into a material amendment to a business combination agreement between HVII, Merger Sub, and ONE Nuclear Energy LLC. Item 1.01 explicitly states that on June 1, 2026, the parties entered into the "Second Omnibus Amendment" extending the outside date for consummating the Business Combination from June 30, 2026 to August 15, 2026, and increasing the promissory note limit from $300,000 to $316,975. This is a material modification to an ongoing M&A transaction that would affect investor assessment of deal timing and financing.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-02
XMax Inc. entered into Securities Purchase Agreements on May 28, 2026 to sell 486,500 shares of common stock at $7.347 per share for an aggregate offering price of $3,574,315.50 in a private placement to non-U.S. investors under Regulation S. This is a classic unregistered equity issuance disclosed under Item 1.01 and Item 3.02, representing dilutive capital raising activity material to investors.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-02
Item 8.01
The company announced completion of a Technical Report Summary (TRS) prepared in accordance with Regulation S-K subpart 1300 by qualified mining consultants (Ausenco Engineering USA South Inc., Independent Mining Consultants, Inc., and WestLand Engineering & Environmental Services, Inc.). This technical assessment with economic analysis of mining operations is material to investors evaluating the company's asset base and operational viability, but does not fit neatly into the standard taxonomy categories (not an earnings release, impairment, going concern, or other defined event type).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
The filing discloses Item 5.07 results from Inspired Entertainment's May 27, 2026 Annual Meeting of Stockholders, including voting outcomes for four proposals: election of seven directors (all elected), advisory approval of named executive officer compensation, frequency of say-on-pay votes (every three years prevailed), and ratification of CBIZ CPAs P.C. as independent auditor. This is a standard shareholder vote results disclosure that is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-06-02
The filing discloses compensatory arrangements for George Archos, the Chair, CEO, and President, including a $2.5 million cash bonus, 2.5 million immediately-vesting RSUs, a base salary increase to $650,000 retroactive to January 1, 2026, and annual long-term incentive awards totaling $1.1375 million in RSUs and cash. While the filing also mentions cancellation of his prior employment agreement, the principal disclosed action centers on the new compensation structure and awards, making this an exec_compensation event under Item 5.02(e).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-02
The filing discloses results of a special meeting of stockholders held on May 27, 2026, with detailed voting tallies on three proposals: (1) amendment to increase authorized shares from 14.6M to 150M, (2) approval of a convertible loan agreement with potential share issuance, and (3) ratification of auditors. Item 5.07 explicitly reports the voting results with vote counts for each proposal. The increase in authorized shares and approval of the convertible loan agreement are material to investors assessing capital structure and dilution risk.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-02
Item 7.01
FingerMotion disclosed a strategic evolution involving diversification, international expansion, and evaluation of AI-HPC opportunities. While no definitive agreements exist yet, the announcement of a material shift in corporate direction and CEO commentary about "evolution of FingerMotion's long-term strategy" and potential participation in emerging sectors would affect a reasonable investor's assessment of the company's future trajectory and capital allocation priorities. This does not fit neatly into M&A activity (no definitive agreements), earnings release, or other specific categories, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-02
Item 1.01
This Item 1.01 discloses the entry into a material definitive agreement—the Pooling and Servicing Agreement dated March 1, 2026, which created the Benchmark 2026-V21 Mortgage Trust and caused the issuance of commercial mortgage pass-through certificates backed by 41 fixed-rate mortgage loans secured by 68 commercial, multifamily, and manufactured housing properties. The closing occurred on March 26, 2026, and the transaction represents a material securitization event involving the creation of a new trust entity and issuance of securities.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-06-02
Item 5.02
The disclosure centers on material changes to Mario Schlosser's compensatory arrangements under an amended and restated employment agreement, including reduction of base salary to $370,000, elimination of annual bonus eligibility, removal of long-term incentive/equity awards, and elimination of severance and healthcare benefits. While Schlosser's role transitions from President of Technology and CTO to Co-Founder & Advisor, the substantive focus of the filing is the restructuring of his compensation package, which would materially affect investor assessment of executive compensation and retention strategy.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-02
Item 7.01
Shopify's Board authorized an additional US$3.0 billion share repurchase program, bringing total authorization to US$5.0 billion. While share repurchases are capital allocation decisions that affect shareholder value and EPS, they do not fit neatly into the standard 8-K taxonomy (not earnings, M&A, executive changes, impairments, or other defined categories). This is material to investors as it signals management confidence and affects capital structure, but is best classified as other_material rather than forced into an inapplicable category.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a clear disclosure of shareholder voting results from Arista Networks' 2026 Annual Meeting held on May 29, 2026. The filing reports the outcomes of three proposals: election of three Class III directors (Lewis Chew, Greg Lavender, and Mark B. Templeton were all duly elected), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The specific vote tallies for each proposal are provided, making this a textbook shareholder_vote_results disclosure under Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-02
Item 8.01
Strive announced a material bitcoin purchase of 2,500 BTC at ~$74,092 per coin (totaling ~$185 million) during May 23–June 1, 2026, along with updates to cash, bitcoin holdings, and share counts. This represents a significant treasury activity and capital deployment that would affect a reasonable investor's assessment of the company's financial position and strategy. While the disclosure does not fit neatly into the standard taxonomy (not M&A, not a dilutive issuance, not an impairment), the magnitude and strategic nature of the bitcoin acquisition and the accompanying balance-sheet updates constitute a material event requiring disclosure under Item 8.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This Item 5.07 filing discloses the results of TPG Twin Brook Capital Income Fund's 2026 Annual Meeting of Shareholders held on May 28, 2026, including voting results for the election of a Class I Trustee (Lance A. Ludwick) and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstentions, Broker Non-Votes) are the core disclosure required under Item 5.07 for shareholder meeting outcomes.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-02
Item 2.02
Yext disclosed financial results for the fourth fiscal quarter ended April 30, 2026, through an Earnings Release and Stockholder Letter attached as exhibits.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-02
Item 8.01
The Board approved an additional $100 million share repurchase authorization on May 30, 2026, increasing the existing program.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-02
Item 7.01
IAC received a non-renewal notice from Google on December 10, 2025, causing the Services Agreement to expire on April 30, 2026, resulting in the cessation of the entire Search segment. The company has reclassified the Search segment as discontinued operations under ASC 205. While this involves segment discontinuation and material operational change, it does not fit neatly into the more specific categories (it is not a restatement, impairment charge, or M&A activity, though it has elements of operational restructuring). The materiality is clear given the elimination of an entire reportable segment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-02
Item 2.02
GitLab Inc. issued a press release on June 2, 2026 announcing financial results for the fiscal quarter ended April 30, 2026, disclosing the company's periodic financial performance and results of operations.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-02
Item 2.05
GitLab's board approved a restructuring plan affecting approximately 14% of its global workforce and exiting 22 countries, with expected pre-tax charges of $30–$35 million. The restructuring involves significant workforce reduction and organizational realignment rather than a discrete asset disposal.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-02
Item 8.01
Arvinas announced a strategic re-prioritization of its pipeline following a strategic review, halting internal development of ARV-806 beyond Phase 1 monotherapy and seeking out-licensing for further clinical trials. This represents a material change in the company's development strategy and resource allocation affecting investor expectations regarding pipeline advancement and cash burn.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-02
Item 5.02
The filing discloses Board-approved changes to non-employee director compensation effective after the 2026 Annual Meeting, including modifications to annual cash retainers ($37,500), equity retainers ($75,000), and committee chair fees. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from executive departures or appointments. The changes are material as they affect the total compensation structure for the Board's non-employee directors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 45%
filed 2026-06-02
Item 1.01
Cactus amended its credit facility to extend the maturity date of a delayed draw term loan facility from June 1, 2026 to December 31, 2026, materially extending the company's financial flexibility and commitment deadline for the undrawn facility.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from ACV Auctions' May 27, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on three proposals: election of directors (Brian Hirsch and Eileen Kamerick as Class II directors), advisory approval of named executive officer compensation, and ratification of Ernst and Young LLP as independent auditor. All three proposals passed with substantial majorities, making this a material governance event that investors track.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-02
Item 7.01
The filing discloses The Eastern Company's acquisition of two entities, Sungear and Crown Precision, announced via press release on June 2, 2026. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.01 (Business Combinations), the substance is clearly a material acquisition activity that would affect a reasonable investor's assessment of the registrant's strategic direction and financial position.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-02
Item 2.03
This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint-and-several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of specific issuance amounts, dates, or terms in the main text (with details relegated to Schedule A) suggests this is a routine periodic disclosure of ongoing funding activity rather than a discrete material event. This falls outside the more specific event categories and is best classified as other_material given the regulatory materiality assertion and the Bank's ongoing reliance on consolidated obligations for funding.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-02
Item 1.01
Hertz issued $1 billion in aggregate principal amount of asset-backed securitized notes ($500M Series 2026-1 and $500M Series 2026-2) through its bankruptcy-remote subsidiary HVF III on May 28, 2026, used to refinance existing debt and acquire/finance fleet vehicles. This material financing arrangement represents a significant capital structure transaction affecting the registrant's financial obligations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-02
Item 1.01
US Foods entered into a material amendment to its ABL Credit Agreement on May 28, 2026, increasing total commitments from $2.3 billion to $2.5 billion, extending the maturity date to May 28, 2031, and modifying pricing and covenant terms. This amendment represents a material modification to the company's capital structure and financing arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Shareholders' Meeting held on May 28, 2026, covering five matters: election of two Class II directors (Albert L. Lord and Thomas J. DeRosa), advisory approval of named executive officer compensation, advisory frequency vote on compensation votes, approval of the 2026 AppTech Equity Incentive Plan, and ratification of dbbmckennon, LLC as independent auditor. The filing presents vote tallies (For, Against, Abstain, Withheld, Broker Non-Votes) for each matter, which is the standard format for Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-02
Item 3.02
The filing discloses an unregistered private placement of Series A Convertible Preferred Stock under Rule 506(b) of Regulation D, with 203,263 shares sold during May 15–June 1, 2026 for $2,006,000 in aggregate proceeds. The convertible nature of the preferred stock and the ongoing offering of up to $200 million in total capacity signal potential dilution to common equity holders. This is a classic dilutive issuance disclosure under Item 3.02.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-02
Item 8.01
The filing discloses an extension of the early tender deadline for an exchange offer and consent solicitation relating to the Company's 5.00% Convertible Senior Notes due 2027. While this involves debt restructuring activity, it does not fit cleanly into the ma_activity category (which typically covers acquisitions, dispositions, mergers, or changes of control) nor any other specific event type. The extension of a tender deadline for an outstanding debt exchange is a material corporate action affecting security holders and creditors, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
Item 5.02
Mr. Einav Eliraz was appointed Chief Financial Officer of VisionWave IL Ltd. (a wholly-owned subsidiary) effective June 1, 2026, with an employment agreement disclosing his salary, performance bonus eligibility, and a material equity grant of 500,000 options. The filing emphasizes his anticipated significant role in the Company's consolidated financial reporting, SEC compliance, M&A activities, and strategic initiatives across global operations, making this a material executive appointment despite the subsidiary structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-02
Item 1.01
KLX Energy Services Holdings completed the acquisition of assets from Wolf Pack Rentals for $17.0 million in cash and deferred stock consideration on June 2, 2026, pursuant to an asset purchase agreement. The transaction includes contingent equity consideration and represents a material strategic acquisition affecting the registrant's financial position and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-02
Item 3.02
KLX issued up to 3,962,440 shares (19.9% of outstanding) as deferred acquisition consideration to Wolf Pack Rentals and 627,521 shares in debt-for-equity exchanges with Senior Secured Notes noteholders, representing substantial dilution to existing shareholders under private placement exemptions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This Item 5.07 disclosure reports the results of Sensus Healthcare's Annual Meeting of Stockholders held on May 29, 2026, including the election of two Class II directors (Eric Sachetta and Michael J. Sardano), an advisory vote on executive compensation, and ratification of Carr, Riggs & Ingram, LLC as independent auditor. The tabulated vote counts for each matter are provided, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →